Category: Press Releases

Amylyx Announces $5 Million Series A Financing to Support Phase II Clinical Trial of AMX0035 for Treatment of Amyotrophic Lateral Sclerosis Cambridge, Mass. (August 22, 2016) — Amylyx Pharmaceuticals Inc. announced today that it has completed a $5 million Series A financing to support its upcoming Phase II trial in patients with Amyotrophic Lateral Sclerosis […]

The ALS Association and ALS Finding a Cure Announce Joint Funding Support for Amylyx Clinical Trial of AMX0035 for the Treatment of ALS July 20, 2016 08:00 AM Eastern Standard Time Washington, D.C. and Cambridge, Mass. (July 20, 2016) — The ALS Association and Amylyx Pharmaceuticals based in Cambridge, Mass. are pleased to announce that […]

Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors | Business Wire January 19, 2016 10:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, a privately-held pharmaceutical company focused on disease-modifying treatments for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases, today announced the election of Nobel Laureate and former Biogen […]

Amylyx Announces Support from the ALS Finding a Cure Foundation and the Cure Alzheimer’s Fund to Bring a New Treatment for Amyotrophic Lateral Sclerosis to Clinical Trials Novel therapeutic blocks nerve cell death and inflammation Clinical trials slated for 2016 Cambridge, MA, November 17, 2015 – Amylyx Pharmaceuticals today announced it has received $600,000 from […]